Ross Baker

Low-Molecular-Weight Heparin versus a Coumarin for the Prevention of Recurrent Venous Thromboembolism in Patients with Cancer

Agnes Lee, Mark N. Levine, Ross Baker et al. · New England Journal of Medicine · 2003 · 2.5K citations · Full text

Randomized Comparison of Low Molecular Weight Heparin and Coumarin Derivatives on the Survival of Patients With Cancer and Venous Thromboembolism

Agnes Lee, Frederick R. Rickles, Jim A. Julian et al. · Journal of Clinical Oncology · 2005 · 453 citations · Full text

Isatuximab, carfilzomib, and dexamethasone in relapsed multiple myeloma (IKEMA): a multicentre, open-label, randomised phase 3 trial

Philippe Moreau, Meletios Α. Dimopoulos, Joseph Mıkhael et al. · The Lancet · 2021 · 366 citations

Hematological Malignancy, Relapsed Multiple Myeloma, Medicine +11

Phase 3 Study of Recombinant Factor IX Fc Fusion Protein in Hemophilia B

Jerry S. Powell, John Pasi, Margaret V. Ragni et al. · New England Journal of Medicine · 2013 · 347 citations · Full text

Persistent endotheliopathy in the pathogenesis of long COVID syndrome

Helen Fogarty, Liam Townsend, Hannah Morrin et al. · Journal of Thrombosis and Haemostasis · 2021 · 324 citations · Full text